Rituximab for the maintenance of minimal change nephropathy – A report of two pregnancies
Sign Up to like & getrecommendations! Published in 2020 at "Obstetric Medicine"
DOI: 10.1177/1753495x18813739
Abstract: Rituximab targets the CD20 antigen expressed on B-lymphocytes and is used to treat recurrent minimal change disease, but experience of its use in pregnancy is limited. We describe a 28-year-old Caucasian female, with recurrent nephrotic… read more here.
Keywords: change; maintenance minimal; rituximab maintenance; minimal change ... See more keywords